Tue06022020

Robins Global News & Noticias



COVID-19 Map Tracker | COVID-19 News Features


  • Career Exam Study
    Career Exam Study
  • Digital Products
    Digital Products
  • Teen Drug Prevention
    Teen Drug Prevention
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Royalty Pharma Files Registration Statement for Proposed Initial Public Offering


NEW YORK, May 23, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to its proposed initial public offering of its Class A ordinary shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions. 

J.P. Morgan, Morgan Stanley, BofA Securities, Goldman Sachs & Co. LLC, Citigroup and UBS Investment Bank are acting as joint lead book-running managers and as representatives of the underwriters for the proposed offering. Evercore ISI, Cowen and SunTrust Robinson Humphrey are also acting as joint book-running managers for the proposed offering.

This offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus relating to the proposed initial public offering may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-866-803-9204 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it. or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014. 

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Royalty Pharma

Founded in 1996, Royalty Pharma is a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and four development-stage product candidates.

Media and Investor Inquiries:
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1 (212) 883-0200



Posted: 2020-05-23 18:02:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.








Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Royalty Pharma Files Registration Statement for Proposed Initial Public Offering | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

NetEase Launches Hong Kong Initial Public Offering

Mon, 01 Jun 2020 04:24:00 GMT

HANGZHOU, China, June 1, 2020 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES) ("NetEase" or "the Company") today announced the launch of its Hong Kong Public Offering, which forms part of the Global ...

ZoomInfo Announces Launch of Its Initial Public Offering

Wed, 27 May 2020 04:39:00 GMT

VANCOUVER, Wash.-(BUSINESS WIRE)-ZoomInfo Technologies Inc. ("ZoomInfo") today announced the launch of its initial public offering of 44,500,000 shares of its Class A common stock. The initial public ...

Royalty Pharma Files Registration Statement for Proposed Initial Public Offering

Sat, 23 May 2020 12:41:00 GMT

When available, a copy of the preliminary prospectus relating to the proposed initial public offering may be obtained ... A registration statement relating to these securities has been filed ...

Royalty Pharma Files Registration Statement for Proposed Initial Public Offering

Sat, 23 May 2020 11:02:00 GMT

Royalty Pharma plc today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to its proposed initial public offering ...

Online Automotive Retailer Vroom Announces Filing of Registration Statement for Proposed Initial Public Offering

Mon, 18 May 2020 14:56:00 GMT

NEW YORK--(BUSINESS WIRE)--Vroom, Inc. (“Vroom”) today announced that it has filed a registration statement on ... relating to the proposed initial public offering of its common stock.

Related News Story Videos From Youtube






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.